Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 39. Отображено 39.
14-04-2017 дата публикации

PHARMACEUTICAL COMPOSITION CONTAINING MELIOSMA OLDHAMII EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MULTI-DRUG RESISTANT CANCER

Номер: KR1020170041030A
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing or treating multi-drug resistant cancer, and to a health functional food, wherein the pharmaceutical composition contains a Meliosma oldhamii extract as an active ingredient. In particular, when the Meliosma oldhamii extract which is an active ingredient is treated to normal cells, cytotoxicity is rarely shown. However, cytotoxicity is shown in various cancer cell strains, and the viability of cancer cells in cell strains having resistance due to the administration of an anticancer agent is reduced. Accordingly, the Meliosma oldhamii extract of the present invention is expected to be effective for a patient having multi-drug resistance to an anticancer agent, and is prescribed along with an anticancer agent as an assisting agent, so the possibility of increasing the effect of an anticancer agent is ensured. COPYRIGHT KIPO 2017 ...

Подробнее
22-02-2016 дата публикации

APTAMER SPECIFICALLY BINDING TO H1 PROTEIN ON INFLUENZA VIRUS, METHOD FOR SENSING INFLUENZA VIRUS USING APTAMER, VECTOR FOR APTAMER, AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSING AND TREATING INFLUENZA VIRUS, COMPRISING APTAMER

Номер: KR1020160019573A
Принадлежит:

The present invention relates to an oligonucleotide aptamer which is composed of specific sequences with capability of inhibiting activity of influenza virus as a causal factor of acute respiratory disease. Specifically, the aptamer has a special affinity stronger than antibodies for H1 HA1 protein on influenza virus and thus is distinguishable from H5 HA1. In addition, the aptamer can inhibits binding capacity of H1 protein. The nucleotide molecule of the present invention has target affinity which is stronger than that of antibodies, is remarkably small in size compared to antibodies, and can bind to the target molecules with high binding force. Furthermore, the nucleotide molecules not sensitive to a temperature variation can be regenerated even after denaturalization in a short amount of time. COPYRIGHT KIPO 2016 ...

Подробнее
26-05-2016 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ANTICANCER AGENT-INDUCED HEMATOPOIETIC TOXICITY, COMPRISING CIBOTIUM BAROMETZ J. SMITH EXTRACT AS ACTIVE INGREDIENT AND HEALTH FUNCTIONAL FOOD

Номер: KR1020160059176A
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing and treating hematopoietic toxicity, comprising a Cibotium barometz J. Smith extract as an active ingredient. More specifically, the Cibotium barometz J. Smith extract of the present invention prevents the effects of various anticancer agents having mechanisms different from each other or prevents the promotion of the growth of cancer cells, and effectively alleviates the hematopoietic toxicity and bone marrow toxicity induced by the anticancer agents. The Cibotium barometz J. Smith extract can be efficiently used as an active ingredient of the pharmaceutical composition for preventing and treating the anticancer agent-induced hematopoietic toxicity. COPYRIGHT KIPO 2016 (A1,A2,A3) Cibotium barometz J. Smith extract(ug/ml) ...

Подробнее
20-07-2016 дата публикации

큰석류풀 추출물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 및 건강기능식품

Номер: KR0101636036B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 큰석류풀 추출물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 및 건강기능식품에 관한 것으로, 구체적으로 본 발명의 큰석류풀 추출물은 다양한 암세포주 및 항암제 내성세포주에 대한 세포독성을 보이므로, 이를 이용한 암환자 및 다제내성 암환자에 대한 치료에 유용하게 이용될 수 있다.

Подробнее
22-09-2017 дата публикации

수선화 추출물 또는 이의 분획물, 및 TRAIL 단백질을 유효성분으로 함유하는 TRAIL-저항성 암의 예방 또는 치료용 조성물

Номер: KR0101781120B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 수선화 추출물 또는 이의 분획물, 및 TRAIL 단백질을 유효성분으로 함유하는 TRAIL-저항성 암의 예방 또는 치료용 약학적 조성물, 또는 TRAIL-저항성 암의 예방 또는 개선용 건강기능식품 조성물에 관한 것이다. 본 발명의 상기 수선화 추출물 또는 이의 분획물은 TRAIL-저항성 암세포에 TRAIL 단백질의 세포독성에 대한 민감성을 증가시키는 효능을 나타내어 암세포의 아폽토시스를 유도하는 효과를 나타냄에 따라, 특히 TRAIL에 저항성을 나타내는 암을 효과적으로 예방, 개선 또는 치료하는 효과를 나타낸다.

Подробнее
15-09-2015 дата публикации

재쑥 또는 백화전호의 추출물 또는 이의 분획물 및 플라티늄계 항암제를 포함하는 암의 예방 또는 치료용 키트

Номер: KR1020150104576A
Принадлежит:

... 본 발명은 암의 예방 또는 치료용 키트 및 암의 예방 또는 치료 방법에 관한 것이다. 보다 구체적으로 본 발명은, a) 재쑥 또는 백화전호의 추출물 또는 이의 분획물을 유효 성분으로 함유하는 제1 조성물; 및 b) 플라티늄계 항암제를 유효 성분으로 함유하는 제2 조성물을 포함하는 암의 예방 또는 치료용 키트, 및 상기 키트를 이용하여 암을 예방 또는 치료하는 방법에 관한 것이다. 또한, 본 발명은 상기 제1 조성물 및 제2 조성물을 병용 투여하여 암을 예방 또는 치료하는 방법에 관한 것이다. 본 발명에 따르면, 상기 제1 조성물 및 제2 조성물을 병용 투여하였을 경우 항암의 시너지 효과를 나타내고, 암 악액질 (Cancer cachexia)을 완화시키고, 플라티늄계 항암제 유도 독성을 감소시키는 효과를 나타낸다.

Подробнее
26-05-2016 дата публикации

PHARMACEUTICAL COMPOSITION AND HEALTH FOOD COMPRISING PERSICARIA FAURIEI EXTRACT AS ACTIVE COMPONENT FOR PREVENTING AND TREATING ANTICANCER AGENT-INDUCED OF HEMATOPOIETIC TOXICITY

Номер: KR1020160059177A
Принадлежит:

The present invention relates to a pharmaceutical composition comprising a Persicaria fauriei extract as an active component for preventing and treating hematopoietic toxicity and, more specifically, to a Persicaria fauriei extract effectively simultaneously relieving medullary toxicity and hematopoietic toxicity derived from an anticancer agent, thereby being used as an active component of a pharmaceutical composition for simultaneously preventing and treating an anticancer agent-induced hematopoietic toxicity, while weakening effects of various anticancer agents having different mechanisms, or not promoting growth of cancer cells. COPYRIGHT KIPO 2016 (A1,A2,A3) Persicaria fauriei extract ...

Подробнее
15-08-2019 дата публикации

COMPOSITION COMPRISING SICYOS ANGULATUS EXTRACT AS EFFECTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF DISEASE ATTRIBUTED TO SIDE EFFECT OF ANTICANCER AGENT

Номер: WO2019156498A1
Принадлежит:

The present invention relates to a composition comprising a Sicyos angulatus extract as an effective ingredient for prevention, alleviation, or treatment of diseases attributed to side effects of an anticancer agent. The Sicyosangulatus extract of the present invention can noticeably recover the survival of hematopoietic stem cells decreased by the administration of anticancer agents, increase expression levels of hematopoiesis-related cytokines (IL-3, IL-6, and IFN-γ), alleviate the hematopoietic toxicity caused by anticancer agents having various acting mechanisms as well as promoting the growth of primary splenic immune cells and NO production in exvivo models, and alleviate hematopoietic toxicity even in invivo models. Therefore, the Sicyos angulatus extract of the present invention can be used as a drug product, a health food, or a supplementary anticancer agent for prevention, alleviation, or treatment of diseases attributed to side effects of anticancer agents.

Подробнее
02-03-2017 дата публикации

가시여뀌 추출물을 유효성분으로 함유하는 항암제 유도 조혈 독성의 예방 및 치료용 약학적 조성물 및 건강기능식품

Номер: KR0101711397B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 가시여뀌(Persicariafauriei) 추출물을 유효성분으로 함유하는 조혈 독성의 예방 및 치료용 약학적 조성물에 관한 것으로, 구체적으로 본 발명의 가시여뀌 추출물은 각기 다른 기전을 가지는 다양한 항암제의 효능을 약화시키거나 암세포의 성장을 촉진하지 않으면서, 동시에 항암제에 의해 유도되는 골수 독성 및 조혈 독성을 효과적으로 완화하므로, 상기 가시여뀌 추출물은 항암제 유도 조혈 독성의 예방 및 치료용 약학적 조성물의 유효성분으로 유용하게 사용될 수 있다.

Подробнее
23-12-2015 дата публикации

PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTING OR TREATING CANCERS COMPRISING PELLIONIA SCABRA BENTH. EXTRACT AS ACTIVE INGREDIENT

Номер: KR101579763B1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a pharmaceutical composition and a health functional food for preventing or treating, comprising a Pellionia scabra Benth. extract as an active ingredient. Specifically, the Pellionia scabra Benth. extract of the present invention shows cytotoxicity against various cancer cell lines and an anti-cancer agent resistant cell line, and thus the composition comprising the extract can be used for treating cancer patients and multi-drug resistance cancer patients. COPYRIGHT KIPO 2016 (AA) Tumor weight(mg) (BB) In ovo tumor transplant model ...

Подробнее
20-02-2017 дата публикации

재쑥 또는 백화전호의 추출물 또는 이의 분획물 및 플라티늄계 항암제를 포함하는 암의 예방 또는 치료용 키트

Номер: KR0101708278B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 암의 예방 또는 치료용 키트 및 암의 예방 또는 치료 방법에 관한 것이다. 보다 구체적으로 본 발명은, a) 재쑥 또는 백화전호의 추출물 또는 이의 분획물을 유효 성분으로 함유하는 제1 조성물; 및 b) 플라티늄계 항암제를 유효 성분으로 함유하는 제2 조성물을 포함하는 암의 예방 또는 치료용 키트, 및 상기 키트를 이용하여 암을 예방 또는 치료하는 방법에 관한 것이다. 또한, 본 발명은 상기 제1 조성물 및 제2 조성물을 병용 투여하여 암을 예방 또는 치료하는 방법에 관한 것이다. 본 발명에 따르면, 상기 제1 조성물 및 제2 조성물을 병용 투여하였을 경우 항암의 시너지 효과를 나타내고, 암 악액질 (Cancer cachexia)을 완화시키고, 플라티늄계 항암제 유도 독성을 감소시키는 효과를 나타낸다.

Подробнее
24-05-2017 дата публикации

COMPOSITION FOR PREVENTION, IMPROVEMENT OR TREATMENT OF PERIPHERAL NEUROPATHY, COMPRISING FORSYTHIA VIRIDISSIMA EXTRACT AS EFFECTIVE COMPONENT

Номер: KR101732483B1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a composition for prevention, improvement or treatment of peripheral neuropathy, especially chemotherapy-induced peripheral neuropathy (CIPN), which is induced by side effects of anticancer drugs, comprising a Forsythia viridissima extract as an effective component. Specifically, the Forsythia viridissima extract does not affect an inherent cytotoxic effect of the anticancer drugs in human cancer cell lines, and at the same time, relieves neurotoxicity caused by the anticancer drugs and inhibition of neurite outgrowth. Moreover, the Forsythia viridissima extract effectively reduces sensitivity to increased pain stimuli in an animal model of the peripheral neuropathy induced by the anticancer drugs. COPYRIGHT KIPO 2017 (A1,A2) WEFF/day oral administration of 250mg/kg ...

Подробнее
04-11-2015 дата публикации

COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL)-RESISTANT CANCER, COMPRISING NARCISSUS TAZETTA VAR. CHINENSIS EXTRACT OR FRACTION THEREOF AND TRAIL PROTEIN AS ACTIVE INGREDIENT

Номер: KR1020150123485A
Принадлежит:

The present invention relates to a pharmaceutical composition for treating or preventing TNF-related apoptosis-inducing ligand (TRAIL)-resistant cancer, comprising a Narcissus tazetta var. chinensis extract or a fraction thereof and TRAIL protein as an active ingredient; or to a functional health food composition for treating or ameliorating TRAIL-resistant cancer. The Narcissus tazetta var. chinensis extract or the fraction thereof in the present invention exhibits efficacy on increasing sensibility against the cytotoxicity of TRAIL protein in a TRAIL-resistant cancer cell, and effects of inducing the apoptosis in the cancer cells. Especially, the extract or the fraction thereof has effects of preventing, ameliorating, or treating cancer showing resistance to TRAIL. COPYRIGHT KIPO 2016 ...

Подробнее
27-12-2016 дата публикации

COMPOSITION FOR PREVENTING, IMPROVING OR TREATING PERIPHERAL NEUROPATHY COMPRISING STEMONAE RADIX EXTRACT AS ACTIVE INGREDIENT

Номер: KR101689513B1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a composition for preventing, alleviating or treating peripheral neuropathy, particularly chemotherapy-induced peripheral neuropathy (CIPN), which comprises an extract of Stemonae Radix as an active ingredient. Particularly, according to the present invention, it is shown that an extract of Stemonae Radix alleviates inhibition against growth of neurites caused by an anti-cancer agent and effectively reduces increased sensitivity to stimuli in an animal model of chemotherapy-induced peripheral neuropath while not causing toxicity in normal cells and not affecting the unique cytotoxic effect of an anti-cancer agent in a human cancer cell line. Thus, the extract of Stemonae Radix can be used as an active ingredient of a composition for preventing, alleviating or treating chemotherapy-induced peripheral neuropathy. COPYRIGHT KIPO 2017 (AA) Reaction rate (%) (BB) Inducing CIPN (CC) Time after drug treatment (wks) ...

Подробнее
04-05-2016 дата публикации

Pharmaceutical compositions and health functional foods comprising Phalaris arundinacea var. picta extracts for preventing or treating multidrug resistant cancers

Номер: KR0101618195B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 흰갈풀 추출물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 및 건강기능식품에 관한 것으로, 구체적으로 본 발명의 흰갈풀 추출물은 다양한 암세포주 및 항암제 내성세포주에 대한 세포독성을 보이므로, 이를 이용한 암환자 및 다제내성 암환자에 대한 치료에 유용하게 이용될 수 있다.

Подробнее
11-01-2018 дата публикации

COMPOSITION COMPRISING FORSYTHIAE FRUCTUS EXTRACT AS EFFECTIVE INGREDIENT FOR PREVENTING, AMELIORATING OR TREATING PERIPHERAL NEUROPATHY

Номер: WO2018008973A1
Принадлежит:

The present invention relates to a composition comprising a Forsythiae Fructus extract as an effective ingredient for preventing, ameliorating or treating peripheral neuropathy, particularly chemotherapy-induced peripheral neuropathy (CIPN). In detail, a Forsythiae Fructus extract of the present invention relieves the neurotoxicity and neurite growth suppression induced by anticancer agents, and effectively reduces sensitivity to increased pain stimuli in animal models with chemotherapy-induced peripheral neuropathy while not affecting the inherent cytotoxicity of anticancer agents in human cancer cell lines.

Подробнее
07-05-2015 дата публикации

KIT COMPRISING A DESCURAINIA SOPHIA OR PEUCEDANUM PRAERUPTORUM EXTRACT OR FRACTION THEREOF AND PLATINUM-BASED ANTICANCER DRUG FOR PREVENTING OR TREATING CANCER

Номер: WO2015065007A1
Принадлежит:

The present invention relates to a kit for preventing or treating cancer and a method for preventing or treating cancer. More specifically, the present invention relates to a kit for preventing or treating cancer and a method for preventing or treating cancer using the kit, wherein the kit comprises: a) a first composition containing a Descurainia Sophia or Peucedanum praeruptorum extract or a fraction thereof as an active ingredient; and b) a second composition containing a platinum-based anticancer drug as an active ingredient. In addition, the present invention relates to a method for preventing or treating cancer by co-administrating the first composition and the second composition. According to the present invention, the co-administration of the first composition and the second composition exhibits a synergetic effect against cancer, mitigates cancer cachexia, and reduces toxicity induced by a platinum-based anticancer.

Подробнее
29-03-2018 дата публикации

ANTITUMOR COMPOSITION OR ANTITUMOR IMMUNITY-INDUCING COMPOSITION COMPRISING ERYSIMUM SP. EXTRACT AS EFFECTIVE INGREDIENT

Номер: WO2018056772A1
Принадлежит:

The present invention relates to an antitumor composition or antitumor immunity-inducing composition comprising an Erysimum sp. extract as an effective ingredient. In the present invention, it is particularly found that Erysimum cheiranthoides and Erysimum macilentum extracts not only have anticancer activity against various carcinomas but also increase calreticulin (CRT) expression and ATP release on a cancer cell surface. Accordingly, the present invention ascertains that cancer cells killed by an Erysimum sp. extract act as an antigen and activate dendritic cells to induce antitumor immunity.

Подробнее
06-07-2016 дата публикации

Pharmaceutical composition and functional food composition for prevention or treatment of angiogenesis-related diseases comprising Meliosma oldhamii Maxim extraction

Номер: KR0101636348B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 혈관신생 관련 질환의 예방 또는 치료에 효과적인, 합다리나무 추출물을 유효성분으로 함유하는 약학적 조성물 및 건강기능식품 조성물에 관한 것이다.

Подробнее
07-05-2015 дата публикации

COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, A MIXED EXTRACT OF ALNUS JAPONICA, DESCURAINIA SOPHIA, AND PEUCEDANUM PRAERUPTORUM, OR A FRACTION THEREOF FOR PREVENTING OR TREATING CANCER

Номер: WO2015064899A1
Принадлежит:

The present invention relates to a composition for preventing, alleviating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition containing, as an active ingredient, a mixed extract of Alnus japonica, Descurainia Sophia, and Peucedanum praeruptorum, or a fraction thereof for preventing or treating cancer; to a functional health food composition containing, as an active ingredient, the mixed extract of Alnus japonica, Descurainia Sophia, and Peucedanum praeruptorum, or the fraction thereof for preventing or alleviating cancer; and to a method for preventing or treating cancer using the composition.

Подробнее
02-08-2017 дата публикации

합다리나무 추출물을 유효성분으로 함유하는 다약제 내성 암의 예방 또는 치료용 약학 조성물 및 건강기능식품

Номер: KR0101763748B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 합다리나무(Meliosmaoldhamii) 추출물을 유효성분으로 함유하는 다약제 내성 암의 예방 또는 치료용 약학 조성물 및 건강기능식품에 관한 것이다. 구체적으로 본원 발명의 유효성분인 합다리나무 추출물을 정상세포에 처리하였을 때는 세포독성이 거의 나타나지 않는 반면에, 다양한 암세포주에서는 세포독성이 나타났을 뿐만 아니라, 항암제의 투여에 의해 내성이 생긴 세포주에서 암세포의 생존능력(viability)을 저하시키는 효과가 있는 것이다. 따라서 본원 발명의 합다리나무 추출물은 항암제의 다중약물내성이 있는 환자에게 효과가 있을 것으로 기대되며, 보조제로 항암제와 병용처방하여 항암제의 효과를 상승시킬 가능성이 있는 것이다.

Подробнее
22-09-2015 дата публикации

METHOD FOR AUTOMATIC CONNECTTING OF WIRELESS LAN BETWEEN DEVICES AND THE DEVICE THEREFOR

Номер: KR0101554743B1
Принадлежит: 삼성전자주식회사

... 본 발명은 무선랜 인터페이스를 가지는 디지털 기기간에 무선랜 통신을 위해 사용자가 SSID, 보안키 및 IP 주소를 직접 입력하지 않고도 디지털 기기간에 무선랜 자동 연결 방법을 제공하는 방법을 제안한다. 이를 위해 디지털 기기간에는 동일한 정보를 이용하여 SSID, 보안키 및 IP 주소를 자동으로 생성해야 하는데, 본 발명에서는 동일한 정보로써 랜덤(random) 정보를 사용한다. 이때, 이 랜덤 정보는 어느 하나의 디지털 기기에서 랜덤하게 생성되는 랜덤 넘버일 수 있다. 이렇게 함으로써 사용자 입장에서는 매번 무선랜 연결을 위한 각각의 정보를 입력하지 않고도 편리하게 무선랜을 이용하는 것이 가능하게 된다. 게다가 디지털 기기측면에서는 연결 시도때마다 변경되는 랜덤 정보의 특성으로 인해 더욱 강화된 보안 특성을 가지게 된다.

Подробнее
01-02-2016 дата публикации

HEALTH FUNCTIONAL FOOD AND PHARMACEUTICAL COMPOSITION COMPRISING MOLLUGO VERTICILLATA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER

Номер: KR1020160011382A
Принадлежит:

The present invention relates to a pharmaceutical composition comprising a Mollugo verticillata extract as an active ingredient for preventing or treating cancer, and to a health functional food. Specifically, the Mollugo verticillata extract of the present invention exhibits cytotoxicity with respect to anticancer drug-resistant cell strains and various cancer cell strains. Therefore, the extract can be usefully used for treating a patient with cancer and a patient with multi-drug resistant cancer by using the same. COPYRIGHT KIPO 2016 ...

Подробнее
17-11-2016 дата публикации

COMPOSITION, CONTAINING LITHOSPERMI RADIX EXTRACT AS ACTIVE INGREDIENT, FOR PREVENTING, ALLEVIATING, OR TREATING PERIPHERAL NEUROPATHY

Номер: WO2016182139A2
Принадлежит:

The present invention relates to a composition, containing a Lithospermi Radix extract as an active ingredient, for preventing, alleviating, or treating peripheral neuropathy, especially, chemotherapy-induced peripheral neuropathy (CIPN). Specifically, it was verified that the Lithospermi Radix extract of the present invention causes no toxicity in normal cells, does not influence an intrinsic cytotoxic effect of an anticancer drug in a human cancer cell line, mitigates the inhibition of neurite growth due to an anticancer drug, and effectively reduces the sensitivity to increased pain stimulation in a chemotherapy-induced peripheral neuropathy animal model, and thus the Lithospermi Radix extract can be favorably used as an active ingredient of the composition for preventing, alleviating, or treating chemotherapy-induced peripheral neuropathy.

Подробнее
31-08-2016 дата публикации

나도송이풀 추출물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 및 건강기능식품

Номер: KR0101652712B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 나도송이풀 추출물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 및 건강기능식품에 관한 것으로, 구체적으로 본 발명의 나도송이풀 추출물은 다양한 암세포주 및 항암제 내성세포주에 대한 세포독성을 보이므로, 이를 이용한 암환자 및 다제내성 암환자에 대한 치료에 유용하게 이용될 수 있다.

Подробнее
02-04-2018 дата публикации

COMPOSITION FOR DERIVING ANTI-CANCER EFFECTS OR ANTI-CANCER IMMUNE RESPONSES, CONTAINING ERYSIMUM SP. EXTRACT AS ACTIVE INGREDIENT

Номер: KR1020180033108A
Принадлежит:

The present invention relates to a composition for deriving anti-cancer effects or anti-cancer immune responses, containing an Erysimum sp. extract as an active ingredient. More specifically, extracts of Erysimum cheiranthoides and Erysimum macilentum have anti-cancer activity against various carcinomas, and also increases expression of calreticulin (CRT) and ATP release on cancer cell surfaces. In addition, cancer cells killed by the Erysimum sp. extract act as an antigen, and activate dendritic cells to induce antitumor immune responses. COPYRIGHT KIPO 2018 (AA) Erysimum cheiranthoides 0.25 (μg/ml) (BB) Erysimum cheiranthoides 0.5 (μg/ml) (CC) Erysimum cheiranthoides 1.0 (μg/ml) (DD) Erysimum cheiranthoides 2.0 (μg/ml) (EE) Doxorubicin (2.0 μM) ...

Подробнее
08-12-2016 дата публикации

구척 추출물을 유효성분으로 함유하는 항암제 유도 조혈 독성의 예방 및 치료용 약학적 조성물 및 건강기능식품

Номер: KR0101684574B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 구척(CibotiumbarometzJ. Smith) 추출물을 유효성분으로 함유하는 조혈 독성의 예방 및 치료용 약학적 조성물에 관한 것으로, 구체적으로 본 발명의 구척 추출물은 각기 다른 기전을 가지는 다양한 항암제의 효능을 약화시키거나 암세포의 성장을 촉진하지 않으면서, 동시에 항암제에 의해 유도되는 골수 독성 및 조혈 독성을 효과적으로 완화하므로, 상기 구척 추출물은 항암제 유도 조혈 독성의 예방 및 치료용 약학적 조성물의 유효성분으로 유용하게 사용될 수 있다.

Подробнее
28-12-2018 дата публикации

양제근 추출물을 유효성분으로 함유하는 항암제 부작용에 의한 질환의 예방, 개선 또는 치료용 조성물

Номер: KR0101932906B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 양제근(Rumecis Radix) 추출물을 유효성분으로 함유하는 항암제 부작용에 의한 질환의 예방 또는 치료용 약학 조성물에 관한 것으로, 양제근 추출물을 마우스의 골수 세포에 처리한 결과, 항암제에 의해 유발된 조혈모세포 집락군의 감소를 현저하게 회복시키고, 항암제를 복강 주사하여 골수억제를 유도한 동물 모델에서 항암제에 의한 골수억제가 현저하게 회복되는 효과가 있다는 것을 확인하였다. 따라서 본 발명의 양제근 추출물은 항암제 부작용에 의한 질환의 예방, 개선 및 치료용 조성물로 유용하게 이용될 수 있으며, 항암 보조제로 항암제와 병용처방하여 항암제의 효과를 상승시킬 가능성이 있는 것이다.

Подробнее
22-02-2016 дата публикации

MOBILE COMMUNICATION TERMINAL OPERATION METHOD AND SYSTEM

Номер: KR0101596038B1
Принадлежит: 삼성전자주식회사

... 본 발명은 전자 디바이스와 연결된 이동 통신 단말의 동작 방법 및 시스템에 관한 것으로, 전자 디바이스가 스크린에 디스플레이된 콘텐츠 중 사용자 선택에 대응하는 콘텐츠를 추출하고, 상기 추출된 콘텐츠와, 상기 추출된 콘텐츠를 실행할 이동 통신 단말의 기능 어플리케이션 정보 및 명령을 상기 이동 통신 단말로 전달하고, 이동 통신 단말이 상기 추출된 콘텐츠와 상기 기능 어플리케이션 정보 및 명령을 수신하고, 상기 추출된 콘텐츠를 이용하여 상기 기능 어플리케이션을 상기 명령에 따라 실행한다.

Подробнее
17-11-2016 дата публикации

COMPOSITION, CONTAINING LITHOSPERMI RADIX EXTRACT AS ACTIVE INGREDIENT, FOR PREVENTING, ALLEVIATING, OR TREATING PERIPHERAL NEUROPATHY

Номер: WO2016182139A3
Принадлежит:

The present invention relates to a composition, containing a Lithospermi Radix extract as an active ingredient, for preventing, alleviating, or treating peripheral neuropathy, especially, chemotherapy-induced peripheral neuropathy (CIPN). Specifically, it was verified that the Lithospermi Radix extract of the present invention causes no toxicity in normal cells, does not influence an intrinsic cytotoxic effect of an anticancer drug in a human cancer cell line, mitigates the inhibition of neurite growth due to an anticancer drug, and effectively reduces the sensitivity to increased pain stimulation in a chemotherapy-induced peripheral neuropathy animal model, and thus the Lithospermi Radix extract can be favorably used as an active ingredient of the composition for preventing, alleviating, or treating chemotherapy-induced peripheral neuropathy.

Подробнее
26-01-2016 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VASCULARIZATION-ASSOCIATED DISORDER, COMPRISING MELIOSMA OLDHAMII MAXIM. EXTRACT AS ACTIVE INGREDIENT AND FUNCTIONAL HEALTH FOOD COMPOSITION

Номер: KR1020160009309A
Принадлежит:

The present invention relates to a pharmaceutical composition which is effective for preventing or treating vascularization-associated disorder and comprises a Meliosma oldhamii Maxim. extract as an active ingredient. The present invention further relates to a functional health food composition. COPYRIGHT KIPO 2016 ...

Подробнее
07-05-2015 дата публикации

COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, MIXED EXTRACT OF ALNUS JAPONICA, DESCURAINIA SOPHIA, AND PEUCEDANUM PRAERUPTORUM, OR FRACTION THEREOF FOR PREVENTING OR TREATING CANCER

Номер: KR1020150048563A
Принадлежит:

The present invention relates to a composition for preventing, alleviating, or treating cancer. More specifically, the present invention relates to a pharmaceutical composition containing, as an active ingredient, a mixed extract of Alnus japonica, Descurainia Sophia, and Peucedanumpraeruptorum, or a fraction thereof for preventing or treating cancer; to a functional health food composition comprising, as an active ingredient, the mixed extract of Alnus japonica, Descurainia Sophia, and Peucedanum praeruptorum, or the fraction thereof for preventing or alleviating cancer; and to a method for preventing or treating cancer using the composition. COPYRIGHT KIPO 2015 ...

Подробнее
19-10-2018 дата публикации

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING DISEASES CAUSED BY SIDE EFFECTS OF ANTICANCER DRUGS CONTAINING RUMECIS RADIX EXTRACT AS ACTIVE INGREDIENT

Номер: KR1020180114554A
Принадлежит:

The present invention relates to a pharmaceutical composition for preventing or treating diseases caused by side effects of anticancer drugs containing a Rumecis Radix extract as an active ingredient. As a result of treating bone marrow cells of a mouse with the Rumecis Radix extract, the reduction of the hematopoietic stem cell group induced by the anticancer agent is remarkably restored, and anticancer drug-induced bone marrow suppression is significantly restored in animal models that induce bone marrow suppression by intraperitoneal injection of anticancer drugs. Therefore, the Rumecis Radix extract of the present invention can be effectively used as a composition for prevention, alleviation and treatment of diseases caused by side effects of anticancer drugs, and the effect of anticancer drugs can be increased by prescribing as the anticancer adjuvant in combination with anticancer drugs. COPYRIGHT KIPO 2018 (AA) docetaxel+Rumecis Radix-125 (BB) docetaxel+Rumecis Radix-250 ...

Подробнее
21-02-2017 дата публикации

자근 추출물을 유효성분으로 함유하는 말초신경병증 예방, 개선 또는 치료용 조성물

Номер: KR0101708165B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 자근(Lithospermi Radix) 추출물을 유효성분으로 함유하는 말초신경병증(peripheral neuropathy), 특히 항암제로 유발된 말초신경병증(chemotherapy-induced peripheral neuropathy, CIPN) 예방, 개선 또는 치료용 조성물에 관한 것으로, 구체적으로 본 발명의 자근 추출물은 정상세포에 독성을 유발하지 않고, 인간 암세포주에서 항암제의 고유한 세포독성 효력에 영향을 주지 않으면서 동시에, 항암제에 의한 신경돌기 성장 억제를 완화하며, 항암제로 유발된 말초신경병증 동물모델에서 증가된 통증 자극에 대한 민감도를 효과적으로 감소시키는 것을 확인함으로써, 상기 자근 추출물은 항암제로 유발된 말초신경병증 예방, 개선 또는 치료용 조성물의 유효성분으로 유용하게 사용될 수 있다.

Подробнее
03-07-2015 дата публикации

COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING ALNUS JAPONICA, DESCURAINIA SOPHIA, AND PEUCEDANUM PRAERUPTORUM DUNN MIXED EXTRACTS OR FRACTION THEREOF

Номер: KR0101533733B1
Принадлежит: 한국 한의학 연구원

... 본 발명은 암의 예방, 개선 또는 치료용 조성물에 관한 것이다. 보다 구체적으로, 본 발명은 오리나무, 재쑥 및 백화전호의 혼합 추출물 또는 이의 분획물을 유효 성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물, 상기 오리나무, 재쑥 및 백화전호의 혼합 추출물 또는 이의 분획물을 유효 성분으로 함유하는 암의 예방 또는 개선용 건강 기능 식품 조성물, 및 상기 조성물을 이용하여 암을 예방 또는 치료하는 방법에 관한 것이다.

Подробнее
01-02-2016 дата публикации

HEALTH FUNCTIONAL FOOD AND PHARMACEUTICAL COMPOSITION COMPRISING PHTHEIROSPERMUM JAPONICUM EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER

Номер: KR1020160011383A
Принадлежит:

The present invention relates to a pharmaceutical composition comprising a Phtheirospermum japonicum extract as an active ingredient for preventing or treating cancer, and to a health functional food. Specifically, the Phtheirospermum japonicum extract of the present invention exhibits cytotoxicity with respect to anticancer drug-resistant cell strains and various cancer cell strains. Therefore, the extract can be usefully used for treating a patient with cancer and a patient with multi-drug resistant cancer by using the same. COPYRIGHT KIPO 2016 ...

Подробнее
11-01-2017 дата публикации

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY COMPRISING EXTRACT OF PHYTOLACCAE RADIX

Номер: KR101695207B1
Принадлежит: KOREA INSTITUTE OF ORIENTAL MEDICINE

The present invention relates to a pharmaceutical composition for preventing or treating chemotherapy-induced peripheral neuropathy comprising an extract of Phytolaccae Radix as an active ingredient. Particularly, it is shown that the extract of Phytolaccae Radix according to the present invention alleviates inhibition of neurite growth caused by chemotherapy, while not causing toxicity to normal cells and not affecting the cytotoxic effect unique to chemotherapy in human cancer cell lines, and effectively reduces the sensitivity to increased stimulation in an animal model of chemotherapy-induced peripheral neuropathy. Thus, the extract of Phytolaccae Radix can be useful for an active ingredient of a pharmaceutical composition for preventing and treating chemotherapy-induced peripheral neuropathy. COPYRIGHT KIPO 2017 ...

Подробнее
22-11-2016 дата публикации

COMPOSITION HAVING LITHOSPERMI RADIX EXTRACT AS EFFECTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING PERIPHERAL NEUROPATHY

Номер: KR1020160133347A
Принадлежит:

The present invention relates to a composition having lithospermi radix extract as an effective ingredient for preventing, alleviating or treating peripheral neuropathy, especially, the chemotherapy-induced peripheral neuropathy which is induced by an anticancer drug. More specifically, the lithospermi radix extract does not cause toxicity to normal cells, nor influence the effect of intrinsic cell toxicity of an anticancer drug in cancer cells of a human body while alleviating the growth of neurite, and highly reducing the sensitivity to nociceptive pain increasing in an animal model for peripheral neuropathy induced by the anticancer drug. Thus, the lithospermi radix extract can be used for an effective ingredient for a composition for preventing, alleviating or treating the peripheral neuropathy induced by the anticancer drug. COPYRIGHT KIPO 2016 (CC) Elapsed time after drug treatment (wks) (BB) Inducing CIPN (AA) Reaction rate (%) ...

Подробнее
16-02-2016 дата публикации

PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD COMPRISING PHALARIS ARUNDINACEA VAR. PICTA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MULTIDRUG RESISTANT CANCER

Номер: KR1020160017434A
Принадлежит:

The present invention relates to a pharmaceutical composition and a health functional food comprising a Phalaris arundinacea var. picta extract as an active ingredient for preventing or treating cancer. Specifically, the Phalaris arundinacea var. picta extract of the present invention exhibits the cytotoxicity with respect to various cancer cell strains and anticancer drug-resistant cell strains, and can be usefully used for treating a patient with cancer and a patient with multidrug resistant cancer by using the same. COPYRIGHT KIPO 2016 (A1,A2) Relative cell viability(MTS measurement) (B1,B2) Phalaris arundinacea var. picta (C1) HL-60/MX2 cell strain (C2) H69-AR cell strain ...

Подробнее